British scientist wins Nobel Prize in Physiology or Medicine

7 October 2019

On 7 October, The Nobel Assembly at the leading medical university Karolinska Institutet announced the decision to award the 2019 Nobel Prize in Physiology or Medicine jointly to scientists Sir Peter Ratcliffe, at Oxford University and Francis Crick Institute, William Kaelin at Harvard University and Gregg Semenza at John Hopkins University. The Laureates won the world-renowned price for their important discoveries of how cells sense and adapt to oxygen availability, thus facilitating further studies in the treatment of a wide range of conditions, including anaemia, cancer, heart failure and chronic lung disease.

Professor Sir Peter Ratcliffe is the Director of the Target Discovery Institute within the Nuffield Department of Medicine at Oxford University, as well as the Director of Clinical Research at Francis Crick Institute in London. He has studied Medicine at Gonville and Caius College at Cambridge University and has specialised in Nephrology at Oxford University, where he also established an independent research group and became a full professor in 1996. In addition, the Laureate is a member of the Ludwig Institute for Cancer Research.

The Nobel Prize is an international award governed by the Nobel Foundation in Stockholm, Sweden. The prestigious prize is in memory of Alfred Nobel, a world-renowned Swedish inventor and entrepreneur. Professor Sir Peter Ratcliffe is the 132nd British Nobel Prize winner, and the 32nd British Laureate of the Nobel Prize in Physiology or Medicine. Since 1901, the Nobel Prizes have been awarded to 935 people and organisations, whereas the Nobel Prize in Physiology or Medicine has been awarded to 112 scientists.

The SCC would like to congratulate the winners for being awarded the prize, thanks to their important contributions to the development of life sciences.

Read the official press release from The Nobel Assembly at Karolinska Institutet

Keep in touch on social

The Link met with Mikael Angesjö, UK Agent at Casall, to disclose the key factors behind the brand's rapid growth in the UK as well as the importance of incorporating sustainability and corporate wellness in the business culture. #Casall #TheLink #SCC
We proudly announce Dr. Johan Christenson, Partner at HealthCap, as keynote speaker at the Life Science Forum 2019. His speech will focus on exploring the next-generation ideas within biotech and their applications for patient benefit. #LifeScienceForum
On 25 November, SCC organises a Business Breakfast with Miles Celic, CEO of TheCityUK. This event aims at addressing the future of the City in the wake of Brexit, as well as discussing financial services on the world markets. #TheCityUK #SwedishChamber

Join our mailing list